Market research
D9Z.F Clínica Baviera, S.A
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 927M
- P/E ratio
- 20.14
- Analyst target
- Not available
- Dividend yield
- 2.8%
- Beta
- 0.72
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- ES0119037010
- Market cap
- 927M
- P/E ratio
- 20.14
- Analyst target
- Not available
- Dividend yield
- 2.8%
- Beta
- 0.72
About
About Clínica Baviera, S.A
Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínica Baviera, S.A. in 2000. Clínica Baviera, S.A. was incorporated in 1992 and is based in Madrid, Spain. Clínica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the D9Z.F discussion.
5 years, 5 months ago
Clínica Baviera, S.A is currently in a long term uptrend where the price is trading 17.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.
Clínica Baviera, S.A's total revenue sank by 6.4% to $33M since the same quarter in the previous year.
Its net income has increased by 12.3% to $5M since the same quarter in the previous year.
Finally, its free cash flow grew by 150.2% to $11M since the same quarter in the previous year.
Based on the above factors, Clínica Baviera, S.A gets an overall score of 4/5.